« Previous
Next »
European Journal of Cancer
Volume 45, Issue 6
, Pages 1067-1079
, April 2009
The cure of cancer: A European perspective
References
- The cure of colon cancer: results from the Eurocare study. Int J Cancer. 1998;77:322–329
- Survival of cancer patients in Europe. The EUROCARE Study. IARC scientific publications no. 132. Lyon: IARC; 1995;
- Survival of cancer patients in Europe. The EUROCARE-2 study. IARC scientific publications no. 151. Lyon: IARC; 1999;p. 1–572
- Survival of cancer patients in Europe: the EUROCARE-3 study. Ann Oncol. 2003;14(5):v1–v155
- . Mixture models for cancer survival analysis: application to population-based data with covariates. Stat Med. 1999;18:441–454
- . The use of mixture models for the analysis of survival data with long term survivors. Biometrics. 1982;38:1041–1046
- . Parametric survival analysis of therapy for stage II breast cancer. Cancer. 1994;74:2483–2490
- The EUROCARE-4 database on cancer survival in Europe: Data standardisation, quality control and methods of statistical analysis. Eur J Cancer. 2009;45:909–930
- SEER∗Stat release 6.3.6. <http://seer.cancer.gov/seerstat/>; 2003 [accessed 25.11.2007].
- . The relative survival rate: a statistical methodology. J Natl Cancer Inst Monogr. 1961;6:101–121
- . The relative survival rate. Cancer. 1995;76:1687–1688
- . Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics. 1982;39:933–942
- Long-term survival expectations of cancer patients in Europe in 2000-2002. Eur J Cancer. 2009;45:1028–1041
- Survival of eight major cancers and all cancers combined for European adults diagnosed in 1995–1999: results of the EUROCARE-4 study. Lancet Oncol. 2007;8:773–783
- Recent cancer survival in Europe: a 2000–2002 period analysis of EUROCARE-4 data. Lancet Oncol. 2007;8:784–796
- Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy. Breast Cancer Res. 2006;8:R68
- . Overdiagnosis and over-treatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening. Breast Cancer Res. 2005;7:230–234
- Overdiagnosis due to prostate-specific antigen screening: lessons from US prostate cancer incidence trends. J Natl Cancer Inst. 2002;94(13):981–990
- Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish cancer registry. Gut. 2005;54:385–387
- EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol. 2003;14:128–149
- . Errors in survival rates caused by routinely used deterministic record linkage methods. Methods Inf Med. 2007;46:420–424
- . The national death index: a largely expected advance in the access to mortality data. Gac Sanit. 2006;20(6):421–423
- Time trends of breast cancer survival in Europe in relation to incidence and mortality. Int J Cancer. 2006;119:2417–2422
- Breast cancer mortality patterns and time trends in 10 new EU member states: mortality declining in young women, but still increasing in the elderly. Int J Cancer. 2004;112:1056–1062
- . Trends in breast cancer incidence, survival and mortality. Lancet. 2000;356:590–592
- EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer. 2009;95:931–991
- Do young breast cancer patients have worse outcomes?. J Surg Res. 2003;113(1):109–113
- . Prostate-specific antigen in the early detection of prostate cancer. CMAJ. 2007;176(13):1853–1858
- . Practice of opportunistic prostate-specific antigen screening in Italy: data from the Health Search database. Eur J Cancer Prev. 2004;13:383–386
- Evidence of prostate cancer screening in a UK region. BJU Int. 2004;93:730–734
- Recent trends in prostate cancer mortality show a continuous decrease in several countries. Int J Cancer. 2008;123(2):421–429
- Under-diagnosis and over-diagnosis of prostate cancer in a screening population with serum PSA 2 to 10
ng/ml. J Urol. 2007;178(1):93–97 - Computed tomography screening and lung cancer outcomes. JAMA. 2007;298(5):518
- Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer. 2003;106:416–422
- . IARC handbooks of cancer prevention: breast cancer screening. vol. 7. Lyon: IARC Press; 2002;p. 1–229
PII: S0959-8049(08)00918-0
doi: 10.1016/j.ejca.2008.11.034
© 2008 Elsevier Ltd. All rights reserved.
« Previous
Next »
European Journal of Cancer
Volume 45, Issue 6
, Pages 1067-1079
, April 2009
